Radiation therapy prolongs the progression-free survival of advanced prostate cancer while maintaining a tolerable safety profile.

Published Date: 12 Jun 2024

The PSMAfore study's new data on adverse events and prolonged prostate-specific antigen (PSA) progression, categorized by safety topic of interest, highlight the radiographic findings that are both statistically significant and clinically significant.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Q&A: When will individuals be able to receive customized cancer vaccines?

2.

Canadian Group Calls for Earlier Colorectal Cancer Screening

3.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

4.

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

5.

Talquetamab Combos Show Survival Benefit in r/r Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot